• LAST PRICE
    0.9731
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.8300/ 1
  • Ask / Lots
    0.9731/ 1
  • Open / Previous Close
    0.0000 / 0.9731
  • Day Range
    ---
  • 52 Week Range
    Low 0.7400
    High 4.6000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.9098
TimeVolumeEVLO
09:32 ET10780.8822
09:35 ET1040.9097
09:42 ET2000.9098
09:46 ET20000.9161
09:48 ET2000.9499
09:50 ET6260.8822
09:51 ET3000.9495
09:53 ET11000.9494
09:55 ET7000.9157
09:57 ET1000.9492
10:02 ET1105000.92785
10:04 ET129200.9496
10:06 ET1000.9496
10:08 ET2000.9496
10:09 ET6000.9496
10:11 ET1000.9448
10:13 ET2000.9496
10:15 ET214460.94
10:18 ET10000.9485
10:20 ET1000.9485
10:22 ET2000.93925
10:26 ET32000.9402
10:27 ET4000.9485
10:29 ET8000.9375
10:31 ET13000.9399
10:33 ET1000.9399
10:36 ET1000.93
10:38 ET1000.9375
10:40 ET1000.9375
10:42 ET2000.9375
10:49 ET3000.9349
10:51 ET1000.9275
10:56 ET3000.925
10:58 ET13800.935
11:00 ET2000.9312
11:02 ET2000.9275
11:09 ET2000.9275
11:16 ET1000.9275
11:23 ET1000.92375
11:25 ET2000.9275
11:27 ET2000.92375
11:30 ET11000.9349
11:34 ET53000.935
11:36 ET9000.935
11:38 ET31340.935
11:39 ET2000.935
11:41 ET5000.935
11:43 ET2000.935
11:48 ET109000.935
11:50 ET12000.93
11:52 ET48500.93
11:54 ET2000.94
11:56 ET2000.93
11:57 ET8960.93
11:59 ET3000.9397
12:01 ET1000.94
12:03 ET1000.94
12:06 ET6000.93975
12:08 ET15010.93975
12:10 ET12000.94
12:12 ET3000.94
12:14 ET8000.9396
12:15 ET1000.93975
12:17 ET1000.9399
12:21 ET2010.9399
12:24 ET1000.9301
12:26 ET3000.93495
12:28 ET2000.9399
12:32 ET25000.9398
12:33 ET2000.9398
12:35 ET3000.9398
12:37 ET1000.9398
12:39 ET3000.9398
12:51 ET5110.9397
12:53 ET5950.9373
12:55 ET1000.9397
12:57 ET5000.9396
01:00 ET2000.9396
01:08 ET4000.9348
01:13 ET1000.9395
01:18 ET2000.93475
01:22 ET1000.93475
01:24 ET2000.93475
01:26 ET4910.93
01:27 ET6000.9324
01:29 ET3000.9324
01:31 ET6000.9348
01:33 ET1000.9348
01:36 ET7640.9348
01:38 ET2350.9274
01:40 ET1000.9348
01:42 ET2000.9274
01:45 ET4850.9274
01:47 ET6000.9348
01:51 ET1000.9299
01:54 ET7000.9299
01:56 ET1000.92495
02:02 ET2000.92495
02:07 ET3000.9249
02:09 ET4000.9249
02:12 ET3000.9298
02:16 ET3000.9249
02:23 ET3000.9297
02:32 ET1000.92485
02:34 ET12000.9297
02:36 ET31810.9333
02:38 ET6000.935
02:39 ET3000.9395
02:41 ET1000.9395
02:43 ET2000.9395
02:45 ET13630.9377
02:48 ET2000.9395
02:50 ET2190.94
02:52 ET1000.939
02:54 ET2000.94
02:56 ET1000.94
02:59 ET58780.945
03:01 ET30630.95
03:03 ET37700.9657
03:06 ET1000.9602
03:10 ET7000.9765
03:12 ET14000.9725
03:14 ET1000.9726
03:17 ET1000.9726
03:19 ET1000.978
03:21 ET1000.9726
03:24 ET1000.9672
03:26 ET29000.9726
03:32 ET129500.97335
03:33 ET5000.97335
03:35 ET8000.969205
03:46 ET3000.9734
03:48 ET43000.9734
03:50 ET3000.9764
03:53 ET9000.9764
03:55 ET2000.9732
03:57 ET17860.9732
04:00 ET53550.9731
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEVLO
Evelo Biosciences Inc
106.7M
-0.5x
---
United StatesINZY
Inozyme Pharma Inc
105.8M
-1.2x
---
United StatesIFRX
InflaRx NV
98.6M
-2.7x
---
United StatesRZLT
Rezolute Inc
105.7M
-1.5x
---
United StatesATOS
Atossa Therapeutics Inc
104.8M
-4.3x
---
United StatesBDTX
Black Diamond Therapeutics Inc
110.9M
-1.2x
---
As of 2023-02-08

Company Information

Evelo Biosciences, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing an orally delivered investigational medicines that acts on cells in the small intestine to produce therapeutic effects throughout the body. It has built a platform to discover and develop oral medicines, which target the small intestinal axis (SINTAX). Its product candidates are orally delivered pharmaceutical preparations of single strains of microbes or microbial extracellular vesicles. Its product candidate, EDP1815, is being developed for the treatment of inflammatory diseases. Its other product candidates in development include EDP1867 and EDP2939 for the treatment of inflammatory disease. It has developed an integrated platform namely, SINTAX Medicine Platform, which is designed to identify individual strains of microbes capable of modulating the immune system by acting on SINTAX when administered at pharmacologically active doses and appropriately formulated.

Contact Information

Headquarters
620 MEMORIAL DRIVE SUITE 500CAMBRIDGE, MA, United States 02139
Phone
617-577-0300
Fax
302-655-5049

Executives

President, Chief Executive Officer, Director
Balkrishan Gill
Chief Financial Officer, Treasurer
Marella Thorell
Chief Scientific Officer, President of Research and Development
Mark Bodmer
General Counsel, Secretary
Daniel Char
Chief Medical Officer
Duncan McHale

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$106.7M
Revenue (TTM)
$0.00
Shares Outstanding
109.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.30
EPS
$-1.78
Book Value
$0.16
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.